Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 5/20 | 0.37 |
| ▸ | MGAM | O43451 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | F7 | P08709 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | DCUN1D1 | Q96GG9 | 1/20 | 0.33 |
| ▸ | TTR | P02766 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | GFER | P55789 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.32 |
| ▸ | GUSB | P08236 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5613530 | 0.80 | IDO1 (0.38) | IDO1MGAMGAAF7SI | |
| SCHEMBL8218688 | 0.80 | MGAM (0.33) | IDO1MGAMGAAF7SI | |
| SCHEMBL83054 | 0.79 | MGAM (0.43) | IDO1MGAMGAAF7SI | |
| SCHEMBL29501455 | 0.79 | MGAM (0.43) | IDO1MGAMGAAF7SI | |
| SCHEMBL991777 | 0.78 | IDO1 (0.36) | IDO1MGAMGAASIMGAM2 | |
| SCHEMBL30640430 | 0.78 | MGAM (0.42) | IDO1MGAMGAAF7SI | |
| SCHEMBL10797942 | 0.74 | GRIN2B (0.42) | ALDH1A1ALOX15HSD17B10HPGDBCL2L1 | |
| SCHEMBL8962327 | 0.74 | MGAM (0.39) | IDO1MGAMGAAF7SI | |
| SCHEMBL2726716 | 0.74 | MGAM (0.39) | IDO1MGAMGAAF7SI | |
| SCHEMBL7099284 | 0.73 | CYP3A4 (0.38) | GAATP53MAPK1MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2775993-B1 | SOLID ANTI-SUN COMPOSITION BASED ON LIPOPHILIC ORGANIC UV SCREENING AGENT AND AEROGEL PARTICLES OF HYDROPHOBIC SILICA | OREAL (FR) | 2018-10-24 | — | — | EP | disclosed |
| US-9233056-B2 | Solid anti-sun composition based on lipophilic organic UV screening agent and aerogel particles of hydrophobic silica | L'OREAL (FR) | 2016-01-12 | — | — | US | disclosed |
| US-9078820-B2 | Oil-in-water emulsion containing an amphiphilic polymer and a silicone elastomer | L'OREAL (FR) | 2015-07-14 | — | — | US | disclosed |
| US-20140294975-A1 | SOLID ANTI-SUN COMPOSITION BASED ON LIPOPHILIC ORGANIC UV SCREENING AGENT AND AEROGEL PARTICLES OF HYDROPHOBIC SILICA | L'OREAL (FR) | 2014-10-02 | — | — | US | disclosed |
| EP-2775993-A1 | SOLID ANTI-SUN COMPOSITION BASED ON LIPOPHILIC ORGANIC UV SCREENING AGENT AND AEROGEL PARTICLES OF HYDROPHOBIC SILICA | L'Oréal (FR) | 2014-09-17 | — | — | EP | disclosed |
| WO-2013068236-A1 | SOLID ANTI-SUN COMPOSITION BASED ON LIPOPHILIC ORGANIC UV SCREENING AGENT AND AEROGEL PARTICLES OF HYDROPHOBIC SILICA | L'OREAL (FR) | 2013-05-16 | — | — | WO | disclosed |
| US-20110088711-A1 | WIPE WITH AN EMULSION CONTAINING A THICKENING POLYMER AND A HYDROPHOBIC MODIFIED INULIN | L'OREAL (FR) | 2011-04-21 | — | — | US | disclosed |
| US-20100221296-A1 | OIL-IN-WATER EMULSION CONTAINING AN AMPHIPHILIC POLYMER AND A SILICONE ELASTOMER | L'OREAL (FR) | 2010-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110088711-A1 | WIPE WITH AN EMULSION CONTAINING A THICKENING POLYMER AND A HYDROPHOBIC MODIFIED INULIN | WIZ, CUTA, WAPL | DPP4 4614/4885IDO1 115/4885MGAM 323/4885 |
| US-20100221296-A1 | OIL-IN-WATER EMULSION CONTAINING AN AMPHIPHILIC POLYMER AND A SILICONE ELASTOMER | IDUA, PLOD3, ABHD16A | DPP4 4774/4885IDO1 3029/4885MGAM 334/4885 |
| US-20140294975-A1 | SOLID ANTI-SUN COMPOSITION BASED ON LIPOPHILIC ORGANIC UV SCREENING AGENT AND AEROGEL PARTICLES OF HYDROPHOBIC SILICA | CUTA, DSG1, KRT18 | DPP4 4547/4885IDO1 3618/4885MGAM 4328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.